Cormedix Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2036
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 28, 2027The maintenance fee for Synthesis of Taurolidine, Purity Profiles and Polymorphs (US 11,738,120) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
- 1 fee due May 19, 2027The maintenance fee for Field Sterilizer and Vascular Connector Kit (US 10,478,640) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
- 1 fee due Jun 30, 2027The maintenance fee for Antimicrobial Wound Closure Materials, Including Antimicrobial Sutures, and Method for Closing a Wound Using the Same (US 10,517,984) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,517,984 | Antimicrobial Wound Closure Materials, Including Antimicrobial Sutures, and Method for Closing a Wound Using the Same In force · High confidence | In force | High confidence | |
| US 11,541,061 | Neuroblastoma Treatment with Taurolidine Hydrolysis Products In force · High confidence | In force | High confidence | |
| US 12,053,478 | Taurultam, Taurinamide and Methylene Glycol Treatment for Myc-Expressing Tumors in Mammalian Bodies In force · Low confidence | In force | Low confidence | |
| US 10,478,640 | Field Sterilizer and Vascular Connector Kit In force · High confidence | In force | High confidence | |
| US 12,302,902 | Antimicrobial Compositions, Including Antimicrobial Hydrogels, Effective Against Mature Biofilms In force · High confidence | In force | High confidence | |
| US 12,016,865 | Methods and pharmaceutical compositions for treating candida auris in blood In force · From the USPTO record | In force | From the USPTO record | |
| US 11,738,120 | Synthesis of Taurolidine, Purity Profiles and Polymorphs In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 pending · 11 abandoned · 5 no status recorded